The baseline patient characteristics of the two groups were similar in terms of menopausal status, histological type, tumor size, lymph node metastasis, histological grade, hormone receptor status, HER2 status, and adjuvant therapy (Table 1). The gene discussed is NR4A1; the disease is metastatic malignant neoplasm in the lymph nodes.